Cleveland BioLabs Inc.

Buffalo, NY, United States

Cleveland BioLabs Inc.

Buffalo, NY, United States
SEARCH FILTERS
Time filter
Source Type

Patent
Cleveland BioLabs Inc. | Date: 2017-08-23

This invention relates, in part, to methods and compositions that are useful for the treatment and/or prevention of various disorders, including radiation-related disorders, such as acute radiation syndrome.


Patent
Cleveland BioLabs Inc. | Date: 2017-06-07

The present invention relates to compositions comprising improved flagellin derived constructs and methods of using the same in the treatment of various diseases.


Patent
Cleveland BioLabs Inc. | Date: 2017-06-07

The present invention relates to, in part, compositions comprising improved flagellin derived constructs and methods of using for vaccination, including adjuvants comprising flagellin-based agents.


Patent
Cleveland BioLabs Inc. | Date: 2016-08-19

The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.


Patent
Cleveland BioLabs Inc. and Cleveland Clinic | Date: 2015-03-11

The present invention relates to treating a tissue in a mammal from the effects of reperfusion using flagellin


Patent
Cleveland BioLabs Inc. and Cleveland Clinic | Date: 2013-07-15

The use of lipopeptides as inducers of NF-B for the protection of mammals from the effects of apoptosis is described.


Patent
Cleveland Clinic and Cleveland BioLabs Inc. | Date: 2015-03-06

The use of lipopeptides as inducers of NF-B for the protection of mammals from the effects of apoptosis is described.


Patent
Cleveland BioLabs Inc. | Date: 2015-03-04

A method is provided for increasing the number of hematopoietic stem cells in the bone marrow, increasing the mobilization of these cells to migrate from the bone marrow to the bloodstream and elsewhere, and increasing the number of differentiating hematopoietic stem cells in the bloodstream.


Patent
Cleveland BioLabs Inc. | Date: 2013-07-02

A method is provided for increasing the number of hematopoietic stem cells in the bone marrow, increasing the mobilization of these cells to migrate from the bone marrow to the bloodstream and elsewhere, and increasing the number of differentiating hematopoietic stem cells in the bloodstream.


Patent
Cleveland BioLabs Inc. | Date: 2015-11-23

The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.

Loading Cleveland BioLabs Inc. collaborators
Loading Cleveland BioLabs Inc. collaborators